January 2023

« Back to 2023
Human Resources  –  Job Postings
Thursday, January 12, 2023
Manager, Graduate Student Systems (Graduate Studies); Marine Instrumental Technologist, Geophysics (Earth & Environmental Sciences).
SuperNOVA  –  General Announcements
Thursday, January 12, 2023
New episode of "What Do Scientists Do?" podcast features Dal Alum Sofya Pesternikova, a Marine Technician with Schmidt Ocean Institute.
Canadian Center for Vaccinology  –  General Announcements
Thursday, January 12, 2023
A clinical study at CCfV to evaluate a new vaccine for pneumococcus bacteria.
Human Resources
Thursday, January 12, 2023
For the individuals who have reached the maximum Canada Pension Plan (CPP) and Employment Insurance (EI) contribution amounts in 2022, your contributions will recommence in January 2023.
Faculty of Open Learning & Career Development  –  Community Highlights
Thursday, January 12, 2023
The Faculty of Open Learning & Career Development delivers custom learning to New Brunswick Community College (NBCC).
Advancement  –  General Announcements
Wednesday, January 11, 2023
Dr. Shelly Whitman has been honoured for her work with the Dallaire Institute for Children, Peace and Security.
Human Resources  –  Job Postings
Wednesday, January 11, 2023
Horticulture Coordinator (Extended Learning - Administration); Website Administrator (Engineering - Dean's Office); Program Evaluation Secretary (Pharmacy); Practice Experience Program Secretary (Pharmacy)
Dal Innovates  –  General Announcements
Tuesday, January 10, 2023
Students interested in entrepreneurship can now apply to the Winter 2023 Collide program.
Centre for Learning and Teaching  –  General Announcements
Tuesday, January 10, 2023
These high-profile awards allow the university community to recognize the outstanding contributions of full-time and part-time faculty and of teaching assistants to the learning experiences of our students.
Canadian Center for Vaccinology  –  General Announcements
Tuesday, January 10, 2023
CCfV is now enrolling female volunteers ages 16-40 for a cytomegalovirus (CMV) vaccine clinical trial.